D-0039-2024 Class III Terminated

Recalled by Amerisource Health Services LLC — Columbus, OH

FDA drug recall D-0039-2024 was initiated by Amerisource Health Services LLC on Sep 1, 2023 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: Out of Specification results in the repackaged product for impurities at the 12-month time point. The recall status is terminated (terminated Jul 16, 2024). Affected quantity: 3,344 cartons.

Recall details

Product Type
Drugs
Report Date
Oct 11, 2023
Initiation Date
Sep 1, 2023
Termination Date
Jul 16, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,344 cartons

Product description

HydrALAZINE Hydrochloride Tablets, USP, 10 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Carton NDC#: 68084-447-01; Individual Dose NDC: 68084-447-11

Reason for recall

Failed Impurities/Degradation Specifications: Out of Specification results in the repackaged product for impurities at the 12-month time point.

Distribution pattern

Nationwide in the USA

Code information

Lot#: 1007002, Exp 12/31/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0039-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0039-2024. Report a data issue: hello@regdatalab.com.